Complement activation in Type 1 human diabetes
- 1 May 1985
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 35 (2) , 211-225
- https://doi.org/10.1016/0090-1229(85)90067-4
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- A prospective analysis of islet-cell cytotoxic antibodies in insulin-dependent diabetic children. Transient effects of plasmapheresisDiabetes, 1984
- Immune islet killing mechanisms associated with insulin-dependent diabetes: Three rabbit antibody-mediated islet cell cytotoxicity modelsDiabetologia, 1983
- Low serum C4 concentrations: an inherited predisposition to insulin dependent diabetes?BMJ, 1983
- Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.The Journal of Immunology, 1983
- Isolation of three separate anaphylatoxins from complement-activated human serumMolecular and Cellular Biochemistry, 1981
- Cytotoxic antibodies to cloned rat islet cells in serum of patients with diabetes mellitus.Journal of Clinical Investigation, 1981
- Cytotoxic Autoantibodies to Beta Cells in the Serum of Patients with Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1980
- Cytotoxic activation of complement by mouse pancreatic islet cellsDiabetes, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- THE SECOND COMPONENT OF HUMAN COMPLEMENT: ITS ISOLATION, FRAGMENTATION BY C'1 ESTERASE, AND INCORPORATION INTO C'3 CONVERTASEThe Journal of Experimental Medicine, 1968